Lime Health AI
Lime Health AI builds Lime Scribe for home health and hospice, a setting almost nothing else in this index serves, and the difference is regulatory rather than cosmetic. Home health documentation is not a SOAP note: it is the OASIS-E2 assessment, the HOPE hospice evaluation, and ICD-10 coding that drives PDGM payment grouping. Lime captures the visit ambiently and auto populates those structured instruments rather than producing narrative, flags missed OASIS sections and weak narratives in real time while the clinician is still in the patient's home, and maps each suggested code to the documentation supporting it. Its oversight model is the strongest located anywhere in this index: a CERTIFIED HOME HEALTH CODER verifies every OASIS item, code and visit detail before anything reaches the EHR, included by default on every engagement rather than sold as a tier, with an audit logged review trail. It syncs bidirectionally with WellSky, MatrixCare, HCHB, Axxess, DSL and Netsmart, effectively the whole post acute EMR market, and works in English or Spanish on iPad and phone for field clinicians.
Capability Axes
Ambient capture and structured assessment generation are the product, and the company's stated trajectory runs outward from the scribe into a full AI native EMR for home health, on the argument that every ambient visit already produces the structured data an EMR stores. The certified coder review layer is verification of model output rather than a services business the AI was added to.
The most complete oversight architecture located in this index, and it edges the others on one word: DEFAULT. A certified home health coder verifies every OASIS item, ICD-10 code and visit detail before anything syncs to the EHR, and the vendor states explicitly that this clinician in the loop review is standard with every engagement and NOT AN UPSELL. Every other human review vendor here, Speke, ScribeRyte, Scribble and Commure, sells verification as a tier a buyer may decline. Three further elements complete it: the reviewer is a CREDENTIALED DOMAIN SPECIALIST rather than a general scribe, which matters when the artifact is a CMS assessment; real time QA flags missed OASIS sections and weak narratives while the clinician is still in the home, so gaps are fixed at source rather than by a return visit; and the review is AUDIT LOGGED, producing a trail of what was checked. Coding is also positioned explicitly as a co pilot suggesting codes for review rather than replacing human judgement.
One genuinely useful architectural feature: ICD-10 suggestions are delivered with CLINICAL EVIDENCE MAPPING, showing which parts of the documentation support each code, which is the same traceability principle that earned Abridge credit for Linked Evidence and is rarer in coding than in note generation. Against that, no accuracy figure, model card, named models or evaluation methodology was located, and the vendor's own time saving claims are inconsistent, appearing as a 75 percent reduction in documentation time in one place and 50 percent in another.
Third party review presence on G2 including a named medical coder and OASIS reviewer, which is a venue the vendor does not control. Beyond that, claims of two to three hours saved daily and elimination of after hours charting carry no denominator, cohort or method, and no study, controlled evaluation, accuracy benchmark or named agency customer was located. Graded C on the standing precedent that adoption and testimony are not evidence of benefit.
The audit logged review trail is a real control and a signed business associate agreement is stated plainly rather than implied. The tension worth naming is the same one this index flagged for Speke, at its maximum here: because coder verification is universal rather than optional, a human workforce reads one hundred percent of charts, not a subset a buyer chose. That is the price of the autonomy A above, and the two should be evaluated together. Nothing was located on where that coder workforce sits, on audio or transcript retention, or on whether customer content trains models.
States HIPAA compliance and a signed business associate agreement directly, alongside audit logging. Specific terms are not published for inspection, and buyers should confirm the agreement covers the certified coder review workforce and not only the software.
Not assessed. Enterprise grade security is a marketing phrase rather than a standard, and no named or dated attestation and no trust centre was located.
Not a regulated medical device and none claimed. The regulatory frame that actually governs this product is CMS assessment and payment policy rather than device oversight: OASIS-E2 and HOPE are mandated instruments and PDGM is a payment model, so accuracy failures surface as survey findings and claim denials rather than as device incidents.
On the coding gradient with the strongest counterweights of any vendor on it. The gradient language is present: ICD-10 codes are described as validated for PDGM OPTIMISATION, and PDGM grouping determines what an episode pays, so optimisation is not a neutral word. What sits against it is unusual. Codes are mapped to the clinical evidence supporting them, so a reviewer can see why each was suggested. Coding is stated to be a co pilot rather than a replacement for human judgement. And a credentialed coder verifies every one before submission, which puts an independent professional between the model's suggestion and the claim, the exact checkpoint this index found missing at OmniMD and MarianaAI. No fairness statement or performance breakdown was located, and language coverage is English and Spanish only.
Effectively complete coverage of one segment's EMR market, with the depth that matters. As of mid 2026 Lime integrates bidirectionally with WellSky, MatrixCare, HCHB, Axxess, DSL and Netsmart, which between them account for the overwhelming majority of home health and hospice agencies. More importantly it syncs STRUCTURED OASIS FIELDS and care plans rather than pushing narrative text, which is the difference between a scribe that saves typing and one that completes the regulatory instrument. Verified notes sync ready for billing with, in the vendor's phrasing, zero rework.
Not assessed. Cloud delivered with iPad, iOS and Android clients suited to field work, but no hosting region, residency option or sub processor detail was located.
No published rate card, tier structure or pricing model located. The mobile application is free to download but the platform is sold to agencies through a demo led process. Worth noting for comparison purposes that the price necessarily includes human coder review of every chart, so it is not comparable with software only per clinician rates elsewhere in this category.
Deep in a setting this index otherwise barely reaches, and specialised at the level of the regulatory instrument rather than the note template. Coverage spans home health and hospice for nurses, therapists and field clinicians, generating OASIS-E2 assessments, HOPE hospice evaluations, daily visit notes, care plans and ICD-10 coding, with PDGM and homebound status documentation handled as first class concerns. The vendor's own argument is the right one: an ambient tool that produces only SOAP notes does not serve this setting, because the document that matters is a structured CMS assessment. English and Spanish. Mobile and iPad first, which suits clinicians documenting in patients' homes rather than at a workstation.
Pricing
Vendor-published figures are labeled as such. Figures labeled “Estimated” are derived from third-party sources and have not been confirmed by the vendor.
| Entry Price | Pricing Basis | BAA Tier | Implementation | Source |
|---|---|---|---|---|
|
Not published. Free app download; platform sold to agencies through demo.
|
Not disclosed. Sold to home health and hospice agencies, with certified coder verification of every chart included by default rather than as an upsell. | HIPAA compliance and a signed business associate agreement stated. Confirm the agreement covers the certified coder review workforce, not only the software. | None published. Native bidirectional integrations with the major post acute EMRs mean no build, and clinicians work from an iPad or phone in the field. | Vendor Published |
Nothing published, and the comparison this price should be held against is not other scribes. Because certified coder review of every chart is included by default rather than sold as a tier, the cost necessarily carries human labour, so it will not compare with software only per clinician rates elsewhere in this category. The right benchmark is what an agency currently spends on OASIS review and coding, which is a real budget line in home health rather than a hypothetical, and the vendor's own claim of zero rework and same day or 24 hour turnaround is testable against it. Two questions before contracting: where the coder workforce operates, since it reads one hundred percent of charts, and what happens to turnaround at volume, since same day review is a staffing promise rather than a software property.